Drugs With ‘Unsupported Price Increases’ Add $5bn To US Spending – ICER

scales measuring price versus value, equal rate
ICER Report Finds Little Evidence Supporting Price Increases
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Drug Pricing

More from Scrip